Dianomi Therapeutics, located in Madison, WI, was established in 2017 to advance the Mineral Coated Microparticle (MCM) technology created by our scientific founders. This innovative technology has the capability to enhance the effectiveness and safety profiles of various drug compounds, and was acquired under license from the Wisconsin Alumni Research Foundation (WARF). Our focus lies in developing a product pipeline targeting inflammatory diseases, as well as forming collaborations with biotech and pharmaceutical firms.
Dianomi Therapeutics
Headquarters
United States of America